Clinical Trial

Chidamide Combination With R-mini CHOP Followed by Chidamide+CD20 Maintenance in Elderly Newly Diagnosed MYC/BCL2+ DLBCL

Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
Efficacy and safety of chidamide in combination with the R-mini CHOP regimen, followed by chidamide plus CD20 monoclonal antibody as maintenance therapy, in elderly patients with newly diagnosed MYC/BCL2 double-expressor DLBCL.
Trial Details
NCT Number NCT07493148
Lead Sponsor Ou Bai, MD/PHD
Conditions Diffuse Large B-Cell Lymphoma (DLBCL)
Enrollment 50 participants
Start Date 2026-04-30
Primary Completion 2029-12-30 (estimated)
Study Completion 2029-12-30 (estimated)
Updated on ClinicalTrials.gov 2026-03-25